Viewing Study NCT03330418


Ignite Creation Date: 2025-12-25 @ 4:34 AM
Ignite Modification Date: 2026-01-10 @ 1:25 AM
Study NCT ID: NCT03330418
Status: RECRUITING
Last Update Posted: 2023-11-27
First Post: 2017-10-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase III Study of TACI-antibody Fusion Protein Injection (RC18) in Subjects With Neuromyelitis Optica Spectrum Disorders
Sponsor: RemeGen Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module